Working… Menu

Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03454035
Recruitment Status : Recruiting
First Posted : March 5, 2018
Last Update Posted : April 14, 2021
BioMed Valley Discoveries, Inc
Information provided by (Responsible Party):
UNC Lineberger Comprehensive Cancer Center

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 24, 2022
Estimated Study Completion Date : October 24, 2023